Literature DB >> 28753391

Differences in forearm strength, endurance, and hemodynamic kinetics between male boulderers and lead rock climbers.

S Fryer1, K J Stone1, J Sveen2, T Dickson1, V España-Romero3, D Giles4, J Baláš5, L Stoner6, N Draper7.   

Abstract

This study examined differences in the oxygenation kinetics and strength and endurance characteristics of boulderers and lead sport climbers. Using near infrared spectroscopy, 13-boulderers, 10-lead climbers, and 10-controls completed assessments of oxidative capacity index and muscle oxygen consumption (m⩒O2) in the flexor digitorum profundus (FDP), and extensor digitorum communis (EDC). Additionally, forearm strength (maximal volitional contraction MVC), endurance (force-time integral FTI at 40% MVC), and forearm volume (FAV and ΔFAV) was assessed. MVC was significantly greater in boulderers compared to lead climbers (mean difference = 9.6, 95% CI 5.2-14 kg). FDP and EDC oxidative capacity indexes were significantly greater (p = .041 and .013, respectively) in lead climbers and boulderers compared to controls (mean difference = -1.166, 95% CI (-3.264 to 0.931 s) and mean difference = -1.120, 95% CI (-3.316 to 1.075 s), respectively) with no differences between climbing disciplines. Climbers had a significantly greater FTI compared to controls (mean difference = 2205, 95% CI= 1114-3296 and mean difference = 1716, 95% CI = 553-2880, respectively) but not between disciplines. There were no significant group differences in ΔFAV or m⩒O2. The greater MVC in boulderers may be due to neural adaptation and not hypertrophy. A greater oxidative capacity index in both climbing groups suggests that irrespective of climbing discipline, trainers, coaches, and practitioners should consider forearm specific aerobic training to aid performance.

Entities:  

Keywords:  Oxidative capacity; blood flow; microvascular adaptation; near infrared spectroscopy; perfusion; sport climbing

Mesh:

Year:  2017        PMID: 28753391     DOI: 10.1080/17461391.2017.1353135

Source DB:  PubMed          Journal:  Eur J Sport Sci        ISSN: 1536-7290            Impact factor:   4.050


  8 in total

1.  The Effects of Prioritizing Lead or Boulder Climbing Among Intermediate Climbers.

Authors:  Nicolay Stien; Tor Frithjof Frøysaker; Espen Hermans; Vegard Albert Vereide; Vidar Andersen; Atle Hole Saeterbakken
Journal:  Front Sports Act Living       Date:  2021-04-22

2.  Comparison of climbing-specific strength and endurance between lead and boulder climbers.

Authors:  Nicolay Stien; Atle Hole Saeterbakken; Espen Hermans; Vegard Albert Vereide; Elias Olsen; Vidar Andersen
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

Review 3.  Tests and Procedures for Measuring Endurance, Strength, and Power in Climbing-A Mini-Review.

Authors:  Nicolay Stien; Atle Hole Saeterbakken; Vidar Andersen
Journal:  Front Sports Act Living       Date:  2022-03-04

4.  The Load Structure in International Competitive Climbing.

Authors:  Marvin Winkler; Stefan Künzell; Claudia Augste
Journal:  Front Sports Act Living       Date:  2022-03-22

5.  Association between MCT1 T1470A polymorphism and climbing status in Polish and Japanese climbers.

Authors:  Mika Saito; Michał Ginszt; Myosotis Massidda; Paweł Cięszczyk; Takanobu Okamoto; Piotr Majcher; Koichi Nakazato; Naoki Kikuchi
Journal:  Biol Sport       Date:  2020-09-04       Impact factor: 2.806

6.  Muscle oxygen dynamics in elite climbers during finger-hang tests at varying intensities.

Authors:  Andri M Feldmann; Daniel Erlacher; Sandro Pfister; Remo Lehmann
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

7.  Masticatory Muscles Activity in Sport Climbers.

Authors:  Michał Ginszt; Grzegorz Zieliński; Aleksandra Byś; Piotr Gawda; Piotr Majcher
Journal:  Int J Environ Res Public Health       Date:  2020-02-21       Impact factor: 3.390

8.  The Estimation of Critical Angle in Climbing as a Measure of Maximal Metabolic Steady State.

Authors:  Jiří Baláš; Jan Gajdošík; David Giles; Simon Fryer
Journal:  Front Physiol       Date:  2022-01-05       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.